Stockreport

Rexahn Announces Move to Nasdaq

REXAHN PHARMACEUTICALS  (RNN) 
NASDAQ:AMEX Investor Relations: investors.rexahn.com
PDF ROCKVILLE, Md., May 28, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative th [Read more]